Market Indices
Latest News
 |
Pure Cycle Corporation (PCYO) confirmed earnings release on July 08, 2026,...
July 8, 2026 PCYO 0.33% |
| ||
| ||
| ||
|
Price Targets
Li Watsek from Cantor Fitzgerald issued a price target of $17.00 for IMRX on 2026-07-08 10:51:57.The adjusted price target was set to $17.00.At the time of the announcement,
July 8, 2026 IMRX 5.20%
from Needham issued a price target of $19.00 for ONDS on 2026-07-07 12:51:10.The adjusted price target was set to $19.00.At the time of the announcement, ONDS was...
July 7, 2026 ONDS 0.07%
from RBC Capital issued a price target of $14.00 for VSTM on 2026-07-07 11:31:28.The adjusted price target was set to $14.00.At the time of the announcement, VSTM...
July 7, 2026 VSTM -1.96%
Brian Kinstlinger from Industrial Alliance Securities issued a price target of $11.00 for LVO on 2026-07-07 11:12:57.The adjusted price target was set to $11.00.At the time of the announcement,...
July 7, 2026 LVO -0.87%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| BZFDW BuzzFeed, Inc. | 0.02
66.90% | ||||||||||||||||||
| ELTX Elicio Therapeutics, Inc. | 3.46
23.57% | ||||||||||||||||||
| AONC American Oncology Network | 12.00
20.00% | ||||||||||||||||||
| BNR Burning Rock Biotech Limi | 11.66
8.52% | ||||||||||||||||||
| RBOT Vicarious Surgical Inc. | 0.17
7.77% | ||||||||||||||||||
| VRCA Verrica Pharmaceuticals I | 6.52
7.41% | ||||||||||||||||||
| SY So-Young International In | 1.66
6.41% | ||||||||||||||||||
| ACET Adicet Bio, Inc. | 9.14
6.28% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 5.33%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -5.91%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -2.97%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -0.11%